Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma. Gaulin C, Jain P, Nair R, Iyer SP, et al. Leuk Lymphoma 2025 Jan 21:1-5. doi: 10.1080/10428194.2025.2454540.

Read + Share

Amedeo Smart

Independent Medical Education

Gaulin C, Jain P, Nair R, Iyer SP, et al. Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma. Leuk Lymphoma 2025 Jan 21:1-5. doi: 10.1080/10428194.2025.2454540.
PMID: 39838574